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Integrative Physiology
Ultrasound and Microbubble-Targeted Delivery of
Macromolecules Is Regulated by Induction of Endocytosis
and Pore Formation
Bernadet D.M. Meijering,* Lynda J.M. Juffermans,* Annemieke van Wamel, Rob H. Henning,
Inge S. Zuhorn, Marcia Emmer, Amanda M.G. Versteilen, Walter J. Paulus, Wiek H. van Gilst,
Klazina Kooiman, Nico de Jong, René J.P. Musters, Leo E. Deelman, Otto Kamp
Abstract—Contrast microbubbles in combination with ultrasound (US) are promising vehicles for local drug and gene
delivery. However, the exact mechanisms behind intracellular delivery of therapeutic compounds remain to be resolved.
We hypothesized that endocytosis and pore formation are involved during US and microbubble targeted delivery
(UMTD) of therapeutic compounds. Therefore, primary endothelial cells were subjected to UMTD of fluorescent
dextrans (4.4 to 500 kDa) using 1 MHz pulsed US with 0.22-MPa peak-negative pressure, during 30 seconds.
Fluorescence microscopy showed homogeneous distribution of 4.4- and 70-kDa dextrans through the cytosol, and
localization of 155- and 500-kDa dextrans in distinct vesicles after UMTD. After ATP depletion, reduced uptake of
4.4-kDa dextran and no uptake of 500-kDa dextran was observed after UMTD. Independently inhibiting clathrin- and
caveolae-mediated endocytosis, as well as macropinocytosis significantly decreased intracellular delivery of 4.4- to
500-kDa dextrans. Furthermore, 3D fluorescence microscopy demonstrated dextran vesicles (500 kDa) to colocalize
with caveolin-1 and especially clathrin. Finally, after UMTD of dextran (500 kDa) into rat femoral artery endothelium
in vivo, dextran molecules were again localized in vesicles that partially colocalized with caveolin-1 and clathrin.
Together, these data indicated uptake of molecules via endocytosis after UMTD. In addition to triggering endocytosis,
UMTD also evoked transient pore formation, as demonstrated by the influx of calcium ions and cellular release of
preloaded dextrans after US and microbubble exposure. In conclusion, these data demonstrate that endocytosis is a key
mechanism in UMTD besides transient pore formation, with the contribution of endocytosis being dependent on
molecular size. (Circ Res. 2009;104:679-687.)
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Conventional delivery methods for drugs or genes, suchas systemic administration via intravenous injection
or oral administration, often do not suffice for therapeutic
compounds such as peptides, silencing RNAs and genes.1
A recent development in delivery systems for therapeutic
compounds is the microbubble– ultrasound (US) interac-
tion.2,3 Before its use as a clinical modality, it is of utmost
importance to obtain new physiological insights into the
mechanisms of uptake by US and microbubble-exposed
cells.
Microbubbles were originally developed as US contrast
agents and are administered intravenously to the systemic
circulation to enhance scattering of blood in echocardiogra-
phy. They consist of a gas core stabilized with an encapsu-
lation, ranging from 1 to 10 m in diameter.4 Nowadays,
research focuses on the use of US and microbubbles for
therapeutic applications. It has been demonstrated that US-
exposed microbubbles can achieve safe and efficient local
delivery of a variety of drugs5,6 and genes.7–9 In an US field,
microbubbles will oscillate, and this may stimulate cells to
admit the drug or gene.10 The advantage of using US and
microbubbles is that only the microbubbles in the US beam
will be activated. In this way, delivery can be targeted to
specific organs or sites by focusing the US beam on the
specific target. This is indicated by the term US microbubble-
targeted delivery (UMTD).
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However, the exact mechanism of cellular uptake of
therapeutics after UMTD is not fully understood. One of the
principal mechanisms is thought to be induction of cell
membrane pores.11,12 Studies using scanning-electron micros-
copy revealed pore-like structures in the cell membrane after
treatment by US either with or without microbubbles.1,8,11,13
The presence of enhanced transmembrane ion fluxes during
US and microbubble exposure was also demonstrated.14,15
Although the hypothesis of pore formation during UMTD is
supported by these studies, it was recently questioned in
studies by Duvshani-Eshet and colleagues.16,17 In these stud-
ies, pore-like structures were found in both US and
microbubble-exposed cells, as well as in control cells.16
Furthermore, atomic-force microscopy studies suggested that
these pore-like structures represented depressions in the
membrane rather than actual pores. Exposing cells to US and
microbubbles altered both diameter and depth of these de-
pressions,17 indicating that the depressions in the membrane
might represent endocytotic invaginations. Interestingly, Juf-
fermans et al recently demonstrated that US-exposed micro-
bubbles induced formation of hydrogen peroxide (H2O2) and
an influx of calcium ions, causing local hyperpolarization of
the cell membrane.11,18 In addition, other studies demon-
strated that H2O2 and a rise in intracellular calcium levels are
directly correlated with endocytosis.19–21
Nevertheless, because there is still no consensus about the
internalization mechanisms involved in UMTD, the aim of
this study was to examine whether macromolecules enter the
cell solely via transient pores, or that endocytosis might also
be involved in the uptake during UMTD. As a model for drug
delivery, uptake of dextrans ranging from 4.4 to 500-kDa in
size was studied. Primary endothelial cells and rat femoral
artery endothelium, the prime target cells for intravenous
microbubbles, were subjected to UMTD of differentially
sized dextran molecules to study whether the mechanism
behind UMTD is dependent on molecular size.
Materials and Methods
Cell Culture
Primary bovine aortic endothelial cells (BAECs) (Cell Applications,
San Diego, Calif) were cultured as described previously.22 Cells
between passage 3 and 7 were used for UMTD experiments.
Forty-eight hours before UMTD, cells were seeded at 33% conflu-
ence to 1 of the 2 gas-permeable, US-transparent membranes of an
Opticell cell culture chamber (Biocrystal, Westerville, Ohio).
Ultrasound Exposure
Before UMTD, the Opticell chamber was mounted in the experi-
mental acoustic setup, described in detail elsewhere22 and, in brief, in
the online data supplement, available at http://circres.ahajournals.org.
Cells were exposed to sine-wave US-bursts with a 6.2% duty cycle
and a 20-Hz pulse repetition frequency for 30 seconds. Peak negative
acoustic pressure generated at the region of interest was 0.22 MPa,
as verified with a calibrated hydrophone (PVDFZ44-0400, Specialty
Engineering Associates, Soquel, Calif).
Preparation of Microbubbles and
Dextran Suspensions
The ultrasound contrast agent Sonovue (Bracco, High Wycombe,
UK) was reconstituted in 5 mL of saline solution according to the
protocol of the manufacturer, resulting in a preparation containing 2
to 5108 microbubbles per milliliter. Tetramethylrhodamine isothio-
cyanate–labeled dextran (4.4, 70, or 155-kDa; Sigma-Aldrich),
fluorescein isothiocyanate (FITC)-labeled dextran (500-kDa; Sigma-
Aldrich), or lysine-fixable FITC-labeled dextran (500-kDa, Molec-
ular Probes, Invitrogen) was added to 125 L of Sonovue, with a
final concentration of 2 mg/mL in 10 mL PBS.
Cellular Distribution
Above described microbubble–dextran solution was added to the
cells directly followed by the US protocol. Immediately after
UMTD, cells were washed with PBS at room temperature and
confocal laser microscopy images were taken with a 100 oil-
immersion lens (Carl Zeiss, Sliedrecht, The Netherlands) to investi-
gate the cellular distribution and localization of the dextran.
Inhibition of Endocytosis During UMTD
To prevent active uptake of extracellular molecules, cells were
depleted from ATP, as described in detail in the online data
supplement. Cells were preincubated with ATP-depletion buffer or
with PBS for 30 minutes, followed by the UMTD protocol. To study
the involvement of different endocytosis pathways, cells were
pretreated 30 minutes with chlorpromazine (15 mol/L; Sigma-
Aldrich), inhibitor of clathrin-mediated endocytosis; filipin (4 g/
mL; Sigma-Aldrich), inhibitor of caveolin-mediated endocytosis; or
wortmannin (0.1 mol/L; Sigma-Aldrich), inhibitor of macropino-
cytosis before UMTD of 4.4-, 70-, 155-, and 500-kDa dextrans. The
specificity of the inhibitor was tested in a separate assay, as
described in the online data supplement. Confocal images were
acquired directly following UMTD using a 40 oil-immersion lens
(Carl-Zeiss).
Immunostaining for Clathrin and Caveolin-1
Directly following UMTD of lysine-fixable FITC-labeled dextran
(500-kDa), regions of interest were cut out the Opticell (1.5 cm2)
and placed in PBS. Cells were fixated and stained with antibodies for
clathrin and caveolin-1, as described in detail in the online data
supplement. Clathrin and caveolin-1 are established markers for
clathrin-mediated and caveolin-mediated endocytosis, respectively.
No appropriate marker for macropinocytosis is available.
In Vivo Dextran Delivery
The animal study was approved by the Animal Research Committee
at the VU University Medical Center. Both femoral arteries of Wistar
rats (n4) were cannulated and infused with microbubble–dextran
(500 kDa, FITC-labeled, lysine-fixable) solution, followed by US
exposure on the left femoral artery. Both arteries were dissected and
stained with antibodies for clathrin and caveolin-1 for detection of
colocalization with dextran. The experimental protocol is described
in detail in the online data supplement.
US and Microbubble-Induced Pore Formation
To study pore formation, the influx of calcium ions was measured
with the fluorescent probe Fluo-4 (Molecular Probes), a cell-
permeant acetoxymethyl ester sensitive for free cytosolic calcium.
To acquire time-lapse images during US exposure the transducer was
mounted on the microscope, as described elsewhere.15 To study the
effect of inhibitors of endocytosis on the US and microbubble-
evoked calcium influx, cells were preincubated 30 minutes with
chlorpromazine, filipin, and wortmannin at concentrations indicated
above before the calcium measurements.
To further investigate pore formation, cells were preloaded with
fluorescent dextrans using the syringe loading protocol of Clarke and
McNeil,23 with minor adaptations described in detail in the online
data supplement. Cells were exposed to US and microbubble
according to the UMTD protocol described above, with the excep-
tion that no dextran was incubated with the microbubbles. Immedi-
ately after US and microbubbles, confocal images were taken using
a 40 oil-immersion lens (Carl Zeiss), and dextran release was
measured.
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Statistics
Data are presented as meansSEM. All experiments were re-
peated at least 3 times. Per condition at least 6 microscopical
fields were analyzed, containing approximately 10 to 20 cells per
field. Groups were tested for normal distribution with one sample
Kolmogorov–Smirnov test. Differences between groups were
tested using a 1-way ANOVA with Bonferroni post hoc analysis
or the nonparametric Kruskal–Wallis test with Dunn’s post hoc
test. Differences between groups in the experiment of calcium
influx were tested using 2-way ANOVA with Bonferroni post hoc
analysis. A probability value of less than 0.05 was considered
statistically significant.
Results
Cellular Distribution of Differently Sized Dextrans
After UMTD dextran molecules of 4.4 kDa showed a homo-
geneous distribution throughout the cytosol as well as in the
nucleus (Figure 1b). Dextran molecules of 70 kDa showed
a similar distribution pattern in the cytosol but were absent
in the nucleus (Figure 1c). Larger dextrans (155 and 500
kDa) showed a different cytosolic pattern of distribution
after UMTD, because they were mainly found in vesicle-
like structures but lacked nuclear localization (Figure 1d
and 1e, respectively). In the absence of US, no uptake of
dextran molecules was found (Figure 1a; results shown for
4.4 kDa).
Inhibition of Endocytosis During UMTD
To further investigate whether vesicle-like dextran-positive
structures found after UMTD were endocytotic vesicles,
UMTD of dextran was studied after overall inhibition of
endocytosis through ATP depletion of the cells as well as
inhibition of specific endocytotic pathways. Deprivation of
cells from ATP resulted in inactivation of the endocytotic
machinery, because these cells were no longer capable to
actively internalize transferrin (Figure 2a through 2c) or
70-kDa dextran (Figure II in the online data supplement).
Interestingly, UMTD of 4.4-kDa dextran was still success-
ful after ATP depletion (Figure 2d through 2f). However,
mean intensity of fluorescence (MIF)SEM decreased by 62%
(no depletion: 365.415.1; ATP depletion: 138.713.3;
P0.001). UMTD of 500-kDa dextran was completely
inhibited when cells were ATP-depleted (Figure 2g
through 2i).
Blocking macropinocytosis (wortmannin) or clathrin-
mediated endocytosis (chlorpromazine) both caused a signif-
icant decrease in MIF after UMTD of all studied dextran sizes
(Figure 3). Filipin, inhibiting caveolin-mediated endocytosis,
caused a significant decrease in MIF after UMTD of dextrans
of 155 and 500 kDa (Figure 3c and 3d) but not for 4.4- and
70-kDa dextrans (Figure 3a and 3b). The specificity and
degree of inhibition was studied separately for each inhibitor
and is described in supplemental Table I.
Colocalization of Endocytosis Markers and
500-kDa Dextran Molecules
To further substantiate the role of endocytosis, we investi-
gated whether internalized 500-kDa dextran colocalizes with
clathrin and/or caveolin-1, which are established markers for
2 main routes of endocytosis. Figure 4 shows clear colocal-
ization of dextran with clathrin (Figure 4b and 4c) and to a
minor extent with caveolin-1 (Figure 4d and 4e), as demon-
strated by the yellow/orange color in the merged images of
dextran (green) and clathrin/caveolin-1 (red). The extent of
colocalization was determined using Pearson’s correlation
factor. A positive correlation was found for dextran with clathrin
was 0.350.06 (P0.001, compared to hypothetical value of
0.0), for dextran with caveolin 0.190.05 (P0.01). As control,
no correlation was found for DAPI (nuclei) with either Cy3
(0.010.01, P0.3) or Cy5 channel (0.010.02, P0.7)
(both secondary antibodies).
In Vivo Dextran Delivery
Results derived from in vivo experiments showed that dex-
tran molecules of 500 kDa were localized in vesicle-like
structures in the endothelium of the rat femoral artery after
UMTD (Figure 5a and 5b). Morphology of the endothelium
Figure 1. Cellular distribution
of fluorescent dextrans after
UMTD. a, No uptake of 4.4-
kDa dextran in the absence of
US. b, Homogeneous distribu-
tion in the cytosol, and nucleus
of 4.4-kDa dextran after
UMTD. c, Homogeneous distri-
bution in the cytosol of 70-kDa
dextran but absence of nuclear
localization. d, Localization of
155 kDa mainly in vesicle-like
structures (see arrows). e,
Vesicular-like localization of
500-kDa dextran.
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and smooth muscle layer are shown in supplemental Figure
III. A movie of the 3D stacked image is shown in the
supplemental Movie file. No dextran was internalized in
control artery not exposed to US. The endothelium was
stained for clathrin and caveolin-1, and clear changes
could be detected in the cellular pattern of both proteins in
the US-exposed artery (Figure 5d and 5f) compared to
control artery (Figure 5c and 5e). Furthermore, part of the
dextran-positive vesicles clearly colocalized with clathrin
(Figure 5d), indicated by the yellow/orange color. Colo-
calization with caveolin-1 was detected to a lesser degree
(Figure 5f). After determining Pearson’s correlation factor,
results similar to the in vitro situation were found. A
positive correlation factor of 0.350.11 was found for
clathrin, as well as for caveolin-1 (0.160.04). Both
correlations were significantly different from the hypothet-
ical value of 0.0 (P0.05). As control, no correlation was
found for DAPI with either Cy3 (0.050.02, P0.7) or
Cy5 (0.040.02, P0.7).
Ultrasound and Microbubble-Induced
Pore Formation
Previously, we ascribed the increase in intracellular calcium
levels after US and microbubbles exposure to transient pore
formation in cardiomyoblast cells.15 Also, US and micro-
bubbles caused influx of calcium ions in BAECs. Fluorescent
intensity reached a peak value of 186.43.4%, followed by a
decrease toward basal levels (Figure 6a). There was no
detectable change in the calcium influx in cells exposed to
either US alone (no microbubbles) (98.20.2%) or micro-
bubbles alone (no US; 97.10.3%), or without both US and
microbubbles (94.30.3%, supplemental Figure IV). To
investigate whether the inhibitors of endocytosis affected the
calcium influx evoked by US and microbubbles, the calcium
influx was also measured in the presence of chlorpromazine,
filipin, and wortmannin. It was found that chlorpromazine
and wortmannin did not significantly affect the US and
microbubble-evoked influx (Figure 6b). However, filipin
caused a large increase in the US and microbubble-evoked
influx (320.47.2%, P0.001).
Furthermore, formation of transient pores was studied by
cellular release of dextran following exposure to US and
microbubbles (Figure 7). Cells were preloaded with dextran,
and following US exposure MIF significantly decreased to
63.42.1% for 4.4-kDa dextran (Figure 7a) and to
79.12.3% for 155-kDa dextran (Figure 7b), compared
to cells not exposed to US and microbubbles (100.02.7%,
P0.05). Because filipin did not inhibit uptake of 4.4- and
70-kDa dextrans and augmented the US and microbubble-
evoked calcium influx, its influence on dextran release was
explored. Treatment with filipin alone, without US and
microbubbles, did not cause a decrease in MIF (100.01.5%,
Figure 7). However, exposure of filipin-treated cells to US
and microbubbles caused significantly more release of the
4.4-kDa dextrans (54.93.1%, P0.05), compared to non–
filipin-treated cells exposed to US and microbubbles
(63.42.1%) (Figure 7a). Filipin-treatment of cells did not
significantly alter the release of 155-kDa dextran (75.62.3%)
after US and microbubble exposure (Figure 7b).
Figure 2. ATP depletion. Con-
focal images demonstrating
uptake of transferrin and fluo-
rescent dextrans (4.4 and 500
kDa) in the absence or pres-
ence of ATP depletion. Cells
were pretreated with PBS (no
depletion) or ATP-depletion
buffer for 30 minutes. a, d, and
g, Relative negative controls;
no transferrin (a) and no UMTD
(d and g). Uptake of transferrin
after 1-hour incubation in PBS
(c) and in ATP-depletion buffer
(d). UMTD of 4.4-kDa dextran
without depletion (e) and after
ATP depletion (f). UMTD of
500-kDa dextran without
depletion (g) and after ATP
depletion (i).
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Discussion
This is, to the best of our knowledge, the first study
demonstrating that endocytosis plays a key role in UMTD of
macromolecules sized between 4 and 500 kDa besides tran-
sient pores. The role of endocytosis was established by
studying cellular localization of dextrans after UMTD, uptake
of dextrans during ATP depletion, and the effect of individual
blockers of the 3 main routes of endocytosis on dextran
uptake. Furthermore, colocalization of 500-kDa dextran with
markers for different endocytosis pathways was demonstrated
in vitro as well as in vivo. In addition to endocytosis, we
demonstrated the occurrence of transient pores in the cell
membrane by showing both influx of calcium ions and
cellular release of preloaded dextrans.
Studying cellular localization of fluorescent dextrans after
UMTD, we found that the smaller dextran molecules of 4.4
and 70 kDa were homogeneously distributed throughout the
cytosol. This is similar to the cellular distribution found after
microinjection of dextran molecules from 3 to 70 kDa into the
cytosol,24,25 indicating that during UMTD the small dextran
molecules enter cells via transient pores in the cell membrane.
In contrast, dextran molecules of 155 and 500 kDa were
mainly localized in vesicle-like structures after UMTD,
indicating that the larger dextrans might be taken up via
endocytosis.26 When these dextran molecules had entered via
pores, a homogeneous cytosolic distribution would be ex-
pected, comparable to the distribution of these dextran
molecules after microinjection.24,25 Therefore, uptake of
Figure 3. UMTD of dextrans in the pres-
ence of endocytosis blockers. Graphs
show MIFSEM for UMTD of all sizes
of dextran, expressed as percentage of
control (nonexposed cells). Significant
reduction in cellular uptake of 4.4-kDa
(a) and 70-kDa (b) dextrans in the pres-
ence of chlorpromazine (CPZ) (clathrin-
mediated uptake) and wortmannin (mac-
ropinocytosis). Filipin (caveolin-mediated
endocytosis) had no significant effect on
the uptake of 4.4 and 70-kDa dextrans.
Significant reduction in cellular uptake
of 155-kDa (c) and 500-kDa (d) dextrans
for all blockers.
Figure 4. Colocalization of
dextran with endocytosis
markers after UMTD. One opti-
cal section from a 3D image
stack is shown. a, Vesicle-like
localization of 500-kDa dextran
in green. b, Immunostaining for
clathrin in red. c, Colocalization
of dextran and clathrin, dem-
onstrated by the yellow/orange
color (indicated by arrows). d,
Immunostaining for caveolin-1
in red. e, Colocalization of dex-
tran and caveolin, demon-
strated by the yellow/orange
color (indicated by arrows).
DAPI was used as nuclear
counterstain.
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larger dextrans through UMTD appears to be mediated
through other pathways than pore formation. After this first
indication of endocytosis, these experiments were repeated
while depriving the cell from ATP. Depleting the cells from
ATP did not stop the 4.4 kDa from entering the cell but did
significantly block the uptake by 62%. This decrease in
fluorescence may be explained by either a 62% contribution
of the endocytotic pathway or by a (partial) washout of the
dextrans taken up via pores as these pores might not have
resealed, because, like all cellular processes, this is also an
energy-dependent process.27 Interestingly, UMTD of 500-
kDa dextran was completely blocked after ATP depletion,
suggesting endocytosis as a route of entry during UMTD.
Endocytosis is further evidenced as an important mechanism
of UMTD by the decrease in cellular uptake of dextran
molecules after inhibition of clathrin-mediated endocytosis,
caveolin-mediated endocytosis, and macropinocytosis. Inter-
estingly, not only the uptake of larger dextrans was inhibited
by the endocytosis inhibitors but also the smaller dextrans
showed a similar decrease after inhibiting clathrin-mediated
endocytosis and macropinocytosis, although the confocal
images of the smaller dextrans indicated uptake via pores.
This discrepancy might be explained by the high level of
fluorescence in the cytosol masking separate vesicles. Fi-
nally, colocalization of 500-kDa dextran with clathrin, and to
a lesser degree caveolin-1, further supported the role of
endocytosis during UMTD.
Importantly, the in vitro findings pointing to the involve-
ment of endocytosis were extended to the in vivo situation.
Using the same US parameters, 500-kDa dextrans were
delivered into endothelium of the rat femoral artery. Confocal
images of the US and microbubble-exposed artery showed
conspicuous changes in the cellular pattern of caveolin-1 and
clathrin, compared to the artery not exposed to US, indicating
translocation of caveolin and clathrin on UMTD. It has been
described in literature that in vitro for example shear stress
can induce translocation of caveolin-1.28,29 Furthermore, the
dextran was clearly localized in vesicle-like structures that
partially colocalized with both clathrin, and to a lesser degree
caveolin-1, comparable to the in vitro data. These in vivo data
Figure 5. UMTD of 500-kDa dextran in
vivo. Images are optical sections from
3D image stacks from the endothelial
layer of the femoral arteries. a, c, and e,
Image from control artery not exposed
to US, demonstrating no dextran
uptake. b, d, and f, Image from artery
exposed to US, demonstrating dextran
(green) uptake by the endothelium and
localization in vesicle-like structures. c
and d, Immunostaining for clathrin in
red. Images demonstrate redistribution
of clathrin-positive vesicles, indicated by
more and larger clathrin-positive vesi-
cles (possibly late endosomes) after
UMTD. Arrows indicate colocalization of
a part of the dextran-positive vesicles
with clathrin. e and f, Immunostaining
for caveolin-1 in red. Images demon-
strate redistribution of caveolin-1, indi-
cated by larger internalized caveolin-
positive vesicles after UMTD, compared
to a well-organized pattern on the cell
membrane. However, minor colocaliza-
tion with dextran is observed (a single
arrow indicating yellow vesicle).
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further substantiated the role of endocytosis in UMTD of
macromolecules to endothelial cells.
All 3 main routes of endocytosis were involved in UMTD
of dextran molecules of 155 and 500 kDa, as demonstrated by
the effect of the inhibitors of these routes of endocytosis.
Caveolin-mediated endocytosis did not seem to be involved
in UMTD of dextran molecules of 4.4 and 70 kDa, because
filipin was not able to block the uptake of these smaller
dextrans. However, it is known that filipin disrupts formation
of caveolae by altering the distribution of cholesterol in the
membrane,30 thereby changing the physical properties of the
membrane. This is confirmed by pretreating the cells with
filipin, followed by exposure to US and microbubbles. Under
these conditions, filipin enhanced the US and microbubble-
induced calcium influx 3-fold. Secondly, filipin augmented
the loss of cytosolic small fluorescent dextrans following
UMTD but did not affect the loss of larger dextrans. To-
gether, these data suggest that filipin increased vulnerability
of the cell membrane and enhanced pore formation during
exposure to US and microbubbles. Thus, caveolin-mediated
endocytosis is also likely to play a role in UMTD of
molecules 70 kDa. Unfortunately, replacing filipin with
another inhibitor of caveolin-mediated endocytosis would
most likely also result in increased formation of transient
pores as these inhibitor all interfere with the physical prop-
erties of the cell membrane.31
We previously demonstrated the occurrence of transient
pores evoked by US and microbubbles in cardiomyoblast
cells. We showed that an increase in intracellular calcium was
caused by the influx of calcium ions from the extracellular
environment through transient pores in the cell membrane.15
In the present study, it was found that also in BAECs, US and
microbubbles evoked a calcium influx. Pore formation caused
by US and microbubbles is further supported by the cellular
release of fluorescent dextrans. Cells preloaded with 4.4-kDa
dextran (diameter of 2.8 nm) showed a decrease in cytosolic
fluorescence down to 63.4% after UMTD compared to only a
small decrease down to 79.1% for 155-kDa dextran (diameter
of 17 nm). This indicates that the contribution of transient
pores is less important for UMTD of macromolecules 155
kDa using our US parameters. These data are in contrast with
the study of Mehier-Humbert et al who suggested that dextran
molecules with a diameter between 11.6 and 37.0 nm were
able to enter the cell via pores, and no differences were found
between molecule sizes.13 However, the role of endocytosis
in cellular entry of these molecules was not excluded in that
study.
It remains unclear how UMTD induces endocytosis. It has
been demonstrated that US-exposed microbubbles may cause
a rise in temperature, which might affect membrane perme-
ability and endocytosis. However, the rise in temperature has
only been demonstrated for cavitating microbubbles.32 Ex-
Figure 6. US- and microbubble-mediated calcium influx. Live-cell measurements of intracellular calcium levels over time. Data are
shown as MIFSEM, expressed as percentages of MIF on t0 seconds. Dotted lines represent moments of US on and off switch,
respectively. a, Increase in MIF during US-exposed microbubbles (black squares). The absence of extracellular calcium in the buffer
resulted in a minor increase in fluorescence, compared to US and microbubbles with calcium (P0.001). b, Effect of endocytosis inhibi-
tors on the US- and microbubble-evoked calcium influx. Chlorpromazine and wortmannin have no significant effect on the US- and
microbubble-evoked calcium influx; however, filipin significantly augmented the US and microbubble-evoked calcium influx (P0.001).
Figure 7. US- and microbubble-mediated cellular
dextran release. a, MIFSEM of 4.4-kDa dextran–
loaded cells after US and microbubble exposure
(gray bars), compared to cells not treated with US
and microbubbles (black bars). US-exposed micro-
bubbles resulted in a significant release of dextran
(P0.05). Pretreatment of cells with filipin before
US and microbubble exposure resulted in signifi-
cantly more dextran release (P0.05), compared to
cells that only received pretreatment with filipin
(without US and microbubbles) and to cells
exposed to US and microbubbles (no filipin). b,
155-kDa dextran–loaded cells. Exposure of cells to
US and microbubbles (gray bars) resulted in a sig-
nificant release of dextran (P0.05), compared to cells not treated with US and microbubbles (black bars). Filipin had no additional
effect on release of 155-kDa dextran. Release of 4.4-kDa dextran was significantly higher than release of 155-kDa dextran after US and
microbubble exposure (P0.05).
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posing microbubbles to US with our parameters does not
cause inertial cavitation and most likely also no increase in
temperature. Several studies demonstrated that shear stress
induces endocytosis in endothelial cells.33–35 Flow of extra-
cellular fluid induced by oscillation of microbubbles in an US
field may cause shear stress and subsequent activation of
endocytotic pathways. Furthermore, US and microbubble-
evoked generation of H2O2, as well as a rise in intracellular
calcium levels, is involved in inducing endocytosis.15,18–21,36
Another recent publication showed that resealing of pores in
the cell membrane, induced by a bacterial toxin, requires
calcium-dependent endocytosis to remove the pores from the
plasma membrane. They also found that this calcium-
dependent endocytosis is required in a similar way to repair
lesions formed in mechanically porated cells,37 which may be
comparable with US and microbubble-porated cells. Besides
US and microbubble-induced uptake via endocytosis, another
route of uptake that has been proposed is fusion of micro-
bubble shell components with the cell membrane, especially
in the case of lipid microbubbles. However, fusion has not yet
been demonstrated experimentally, only suggested.4,38 Further-
more, if fusion does take place, it is to be expected that this will
lead to a homogeneous distribution of the dextran in the cytosol.
In this study, we found a vesicular localization of the larger
dextrans and a key role for endocytosis, arguing against an
important role for fusion.
To summarize, UMTD provides opportunities for new thera-
pies because of its low toxicity, low immunogenicity, noninva-
sive nature, local application, and its cost-effectiveness. Another
advantage over other targeted delivery systems for therapeu-
tic compounds is that molecular imaging and therapeutic
compound delivery can be performed simultaneously.39 The
finding that the contribution of endocytosis and pore forma-
tion to intracellular delivery and subsequent subcellular
localization of the therapeutic compound is dependent on the
molecular size, should be taken into account when designing
new effective therapies using UMTD. Pharmaceutical chem-
ical compounds are generally smaller than 4 kDa and may
have their target in the cytosol or nucleus, because they are
small enough to pass the nuclear pore. Proteins may range
from 4 to 500 kDa. DNA, which needs to enter the nucleus for
effective therapy, often exceeds 500 kDa and is likely to be
trapped in endosomes. This compartmentalization of thera-
peutic compounds and, most importantly genes, may affect
therapy efficiency and should be taken into consideration
when measuring drug action following UMTD. On the other
hand, because many crucial signaling events are known to
occur in these endosomes,40 the endocytotic mechanism could
also be exploited for therapy.
In conclusion, endocytosis plays a key role in UMTD of
molecules sized between 4 and 500 kDa besides transient
pore formation. The contribution of transient pores as a
mechanism of UMTD decreases, when molecule size in-
creases. These findings provide important new insight in the
mechanisms of UMTD and will lead to the rational design of
new drug or gene therapies involving UMTD.
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